Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuan Pharmaceutical Group Yantai Zhi Chu Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of antibiotic active pharmaceutical ingredients (APIs) and finished dosage forms. Based in Yantai, Shandong, the company was acquired by Fuan Pharmaceutical Group in 2016 and serves as a core production hub for fermentation-based anti-infectives. Its extensive portfolio includes aminoglycosides like tobramycin and netilmicin, as well as glycopeptides such as vancomycin and norvancomycin. The company operates high-capacity GMP-certified facilities and is recognized for its expertise in large-scale fermentation and chemical synthesis. Zhi Chu Pharmaceutical supplies both domestic Chinese hospitals and international markets, maintaining a strong position in the global antibiotic supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuan Pharmaceutical Group Yantai Zhi Chu Pharmaceutical.